Creo Medical Group PLC (BST:1RC)

Market Cap	54.05M +6.0%
Revenue (ttm)	5.37M
Net Income	583.30K
EPS	-0.00
Shares Out	n/a
PE Ratio	92.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1320
Previous Close	0.1320
Day's Range	0.1250 - 0.1350
52-Week Range	0.1050 - 0.2100
Beta	n/a
RSI	43.72
Earnings Date	May 20, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 129
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 1RC

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.

Financial numbers in GBP